MedPath

SEA posture in prevention of upper limb spasticity in acute stroke

Phase 3
Conditions
Health Condition 1: G938- Other specified disorders of brain
Registration Number
CTRI/2020/12/029482
Lead Sponsor
Principal Investigator
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

With flaccid upper limb monoparesis/hemiparesis/quadriparesis admitted in neurology ward of Sir Sundarlal Hospital, Institute of Medical Sciences, Banaras Hindu University, Varanasi

Exclusion Criteria

Patients with large ischemic infarct or hemorrhage needing Intensive Care Unit, hemodynamic instability, respiratory distress or on ventilatory support, CNS infection, major head trauma, planned surgical procedure (e.g., decompressive hemicraniectomy) or post-operative cases, hepatic or kidney disease, fracture or limb deformity, malignancy or withdrawal of consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
modified ashworth spasticity scaleTimepoint: at 3 and 6 months
Secondary Outcome Measures
NameTimeMethod
A) modified Rankin Score, Barthel index, Manual Muscle Testing Score, HADS score and use of antispastic medications (timing of initiation, doses, number) or botox therapy <br/ ><br> <br/ ><br>B) Biomarkers like BNP, D-Dimers, MMP-9, NFL and S100 BetaTimepoint: A) At 3 and 6 months <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>B) At 3 months
© Copyright 2025. All Rights Reserved by MedPath